Angiogenesis in osteoarthritis and spondylosis: Successful repair with undesirable outcomes

Current Opinion in Rheumatology

Volumn 16, Issue 5, 2004, Pages 609-615

  Walsh, David A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Back pain; Endochondral ossification; Inflammation; Neovascularization; Nerve growth; Pathologic

Indexed keywords

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; BACKACHE; ENCHONDRAL OSSIFICATION; EXERCISE; HUMAN; INNERVATION; NEOVASCULARIZATION (PATHOLOGY); NERVE GROWTH; OSTEOARTHRITIS; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SPINE; SPONDYLOSIS; SYMPTOMATOLOGY; SYNOVITIS; SYNOVIUM; TISSUE REPAIR; TREATMENT INDICATION; VASCULARIZATION;

CARTILAGE, ARTICULAR; HUMANS; INTERVERTEBRAL DISK; JOINTS; LOW BACK PAIN; NEOVASCULARIZATION, PATHOLOGIC; OSTEOARTHRITIS; OSTEOGENESIS; RECOVERY OF FUNCTION; SPINAL OSTEOPHYTOSIS;

EID: 4344623431     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000133662.60223.ee     Document Type: Review

References (71)

1. Sledge CB, Reddi AH, Walsh DA, et a.: Biology of the normal joint. In Kelley's Textbook of Rheumatology, edn 6. Edited by Ruddy S, Harris ED Jr, Sledge CB. Philadelphia: WB Saunders; 2001:1-26.
2. Urban JP, Holm S, Maroudas A, et al.: Nutrition of the intervertebral disk. An in vivo study of solute transport. Clin Orthop 1977, 129:101-114.
3. Repanti M, Korovessis PG, Stamatakis MV, et al.: Evolution of disc degeneration in lumbar spine: a comparative histological study between herniated and postmortem retrieved disc specimens. J Spinal Disord 1998, 11:41-45.
4. Moses MA, Sudhalter J, Langer R: Identification of an inhibitor of neovascularization from cartilage. Science 1990, 248:1408-1410.
5. Fenwick SA, Gregg PJ, Rooney P: Osteoarthritic cartilage loses its ability to remain avascular. Osteoarthritis Cartilage 1999, 7:441-452.
6. Lotz M, Moats T, Villiger PM: Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest 1992, 90:888-896.
7. Martel-Pelletier J, McCollum R, Fujimoto N, et al.: Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994, 70:807-815.
8. Hiraki Y, Inoue H, Iyama K, et al.: Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem 1997, 272:32419-32426.
9. Pfander D, Cramer T, Deuerling D, et al.: Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage. Ann Rheum Dis 2000, 59:448-454.
10. Mapp PI, Kidd BL, Gibson SJ, et al: Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 1990, 37:143-153.
11. Wojtys EM, Beaman DN, Glover RA, et al.: Innervation of the human knee joint by substance P fibers. Arthroscopy 1990, 6:254-263.
12. Beaman DN, Graziano GP, Glover RA, et al.: Substance P innervation of lumbar spine facet joints. Spine 1993, 18:1044-1049.
13. Brown MF, Hukkanen MV, McCarthy ID, et al.: Sensory and sympathetic innervation of the vertebral endplate in patients with degenerative disc disease. J Bone Joint Surg Br 1997, 79:147-153.
14. Carmeliet P: Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet 2003, 4:710-720. This thought-provoking review brings together angiogenesis and nerve growth, particularly in the context of embryology, but with clear implications for pathology.
15. Neufeld G, Cohen T, Shraga N, et al.: The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 2002, 12:13-19.
16. Mankin HJ, Dorfman H, Lippiello L, et al.: Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971, 53:523-537.
17. Moskowitz RW, Goldberg VM: Studies of osteophyte pathogenesis in experimentally induced osteoarthritis. J Rheumatol 1987, 14:311-320.
18. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31.
19. Paleolog EM, Fava RA: Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies. Springer Semin Immunopathol 1998, 20:73-94.
20. Walsh DA: Angiogenesis and arthritis. Rheumatology (Oxford) 1999, 38:103-112.
21. Walsh DA, Wade M, Mapp PI, et al.: Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 1998, 152:691-702.
22. Ikeda M, Hosoda Y, Hirose S, et al.: Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis. J Pathol 2000, 191:426-433.
23. Shahrara S, Volin MV, Connors MA, et al.: Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res 2002, 4:201-208.
24. Conrozier T, Chappuis-Cellier C, Richard M, et al.: Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis. Rev Rheum Engl Ed 1998, 65:759-765.
25. Spector TD, Hart DJ, Nandra D, et al.: Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997, 40:723-727.
26. Smith MD, Triantafillou S, Parker A, et al.: Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997, 24:365-371.
27. Pelletier JP, Martel-Pelletier J, Abramson SB: Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001, 44:1237-1247.
28. Haywood L, McWilliams DF, Pearson CI, et al.: Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003, 48:2173-2177. This cross-sectional study demonstrates the relationship between macrophage infiltration, VEGF expression, and angiogenesis in synovia from patients with osteoarthritis.
29. Mapp PI, Kidd BL, Gibson SJ, et al.: Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 1990, 37:143-153.
30. Stevens CR, Blake DR, Merry P, et al.: A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum 1991, 34:1508-1513.
31. Ceponis A, Konttinen YT, MacKevicius Z, et al.: Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane. J Rheumatol 1996, 23:1880-1886.
32. Freemont AJ, Watkins A, Le Maitre C, et al.: Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol 2002, 197:286-292.
33. Egginton S, Zhou AL, Brown MD, et al.: The role of pericytes in controlling angiogenesis in vivo. Adv Exp Med Biol 2000, 476:81-99.
34. Ruegg C, Mariotti A: Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Cell Mol Life Sci 2003, 60:1135-1157. Review of integrins and pharmaceutical developments in angiogenesis and in cancer of mechanistic relevance to arthritis.
35. 189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 2001, 44:1082-1088.
36. Koch AE: Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 1998, 41:951-962.
37. Semble EL, Turner RA, McCrickard EL: Rheumatoid arthritis and osteoarthritis synovial fluid effects on primary human endothelial cell cultures. J Rheumatol 1985, 12:237-241.
38. Lupia E, Montrucchio G, Battaglia E, et al.: Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis. Eur J Immunol 1996, 26:1690-1694.
39. Lupia E, Montrucchio G, Battaglia E, et al.: Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis. Eur J Immunol 1996, 26:1690-1694.
40. Koch AE, Harlow LA, Haines GK, et al.: Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994, 152:4149-4156.
41. Koch AE, Halloran MM, Hosaka S, et al.: Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis. Arthritis Rheum 1996, 39:1566-1575.
42. 2 induces vascular endothelial cell migration. Blood 2000, 96:3809-3815.
43. Park CC, Morel JC, Amin MA, et al.: Evidence of IL-18 as a novel angiogenic mediator. J Immunol 2001, 167:1644-1653.
44. Volin MV, Woods JM, Amin MA, et al.: Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol 2001, 159:1521-1530.
45. Pablos JL, Santiago B, Galindo M, et al.: Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 2003, 170:2147-2152. This in vivo model was used to dissect the importance of chemokines in the angiogenic potential of synovial fluids.
46. Walsh DA, Mapp PI, Wharton J, et al.: Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 1993, 142:1610-1621.
47. Gerber HP, Vu TH, Ryan AM, et al.: VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5:623-628.
48. 188. Mech Dev 2002, 111:61-73.
49. Vu TH, Shipley JM, Bergers G, et al.: MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93:411-422.
50. Nagai H, Aoki M: Inhibition of growth plate angiogenesis and endochondral ossification with diminished expression of MMP-13 in hypertrophic chondrocytes in FGF-2-treated rats. J Bone Miner Metab 2002, 20:142-147.
51. Smith JO, Oreffo RO, Clarke NM, et al.: Changes in the antiangiogenic properties of articular cartilage in osteoarthritis. J Orthop Sci 2003, 8:849-857. This is an imaginative approach to characterizing how articular cartilage is hostile to vascular invasion with the potential to investigate matrix as well as soluble factors.
52. West DC, Hampson IN, Arnold F, et al.: Angiogenesis induced by degradation products of hyaluronic acid. Science 1985, 228:1324-1326.
53. West DC, Kumar S: The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989, 183:179-196.
54. Praest BM, Greiling H, Kock R: Assay of synovial fluid parameters: hyaluronan concentration as a potential marker for joint diseases. Clin Chim Acta 1997, 266:117-128.
55. Levick JR: Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure. J Rheumatol 1990, 17:579-582.
56. Giatromanolaki A, Sivridis E, Maltezos E, et al.: Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2003, 5:R193-R201. This study uses hypoxia inducible factor-1α to localize possible regions of hypoxia in synovia, complementing data on hypoxia-responsive genes such as VEGF that are upregulated by inflammatory factors in addition to hypoxia.
57. Peters CL, Morris CJ, Mapp PI, et al: The transcription factors hypoxia-inducible factor 1alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum 2004, 50:291-296. This paper provides further evidence that animal models can mimic the synovial hypoxia observed in human arthritis.
58. Malinin T, Ouellette EA: Articular cartilage nutrition is mediated by subchondral bone: a long-term autograft study in baboons. Osteoarthritis Cartilage 2000, 8:483-491.
59. Graf J, Neusel E, Freese U, et al.: Subchondral vascularisation and osteoarthritis. Int Orthop 1992, 16:113-117.
60. Walsh DA, Hu DE, Mapp PI, et al.: Innervation and neurokinin receptors during angiogenesis in the rat sponge granuloma. Histochem J 1996, 28:759-769.
61. Fortier LA, Nixon AJ: Distributional changes in substance P nociceptive fiber patterns in naturally osteoarthritic articulations. J Rheumatol 1997, 24:524-530.
62. Freemont AJ, Peacock TE, Goupille P, et al.: Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet 1997, 350:178-181.
63. Johnson WE, Evans H, Menage J, et al.: Immunohistochemical detection of Schwann cells in innervated and vascularized human intervertebral discs. Spine 2001, 26:2550-2557.
64. Koltzenburg M: The changing sensitivity in the life of the nociceptor. Pain 1999, (suppl 6):S93-S102.
65. Hukkanen M, Konttinen YT, Rees RG, et al.: Innervation of bone from healthy and arthritic rats by substance P and calcitonin gene related peptide containing sensory fibers. J Rheumatol 1992, 19:1252-1259.
66. Mapp PI, Terenghi G, Walsh DA, et al.: Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neuroscience 1993, 57:1091-1096.
67. Bittner K, Vischer P, Bartholmes P, et al.: Role of the subchondral vascular system in endochondral ossification: endothelial cells specifically derepress late differentiation in resting chondrocytes in vitro. Exp Cell Res 1998, 238:491-497.
68. Mori S, Yoshikawa H, Hashimoto J, et al.: Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2. Bone 1998, 22:99-105.
69. Dequeker J, Mokassa L, Aerssens J, et al.: Bone density and local growth factors in generalized osteoarthritis. Microsc Res Tech 1997, 37:358-371.
70. Hashimoto S, Creighton-Achermann L, Takahashi K, et al.: Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2002, 10:180-187.
71. Roberts S, Caterson B, Menage J, et al.: Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine 2000, 25:3005-3013.